BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19682187)

  • 1. Management of acute peptic ulcers: how ethnicity, different proton pump inhibitors and mechanism of delivery alter the equation.
    Tan VP; Wong BC
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1157-8. PubMed ID: 19682187
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of p.o. or i.v. proton pump inhibitors on 72-h intragastric pH in bleeding peptic ulcer.
    Javid G; Zargar SA; U-Saif R; Khan BA; Yatoo GN; Shah AH; Gulzar GM; Sodhi JS; Khan MA
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1236-43. PubMed ID: 19682194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal dose of intravenous pantoprazole in patients with peptic ulcer bleeding requiring endoscopic hemostasis in Korea.
    Choi KD; Kim N; Jang IJ; Park YS; Cho JY; Kim JR; Shin JM; Jung HC; Song IS
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1617-24. PubMed ID: 19686407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 3-day IV pantoprazole versus omeprazole on 24-hour intragastric acidity at 3 days in Chinese patients with duodenal ulcer: A single-center, prospective, randomized, comparative, pilot trial.
    Lin HJ; Lo WC; Cheng YC; Perng CL
    Clin Ther; 2006 Sep; 28(9):1303-7. PubMed ID: 17062303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Less acid + less bleeding = better outcomes and more money!
    Enns R
    Can J Gastroenterol; 2004 Dec; 18(12):747-8; discussion 748. PubMed ID: 15605140
    [No Abstract]   [Full Text] [Related]  

  • 6. Intragastric pH with oral vs intravenous bolus plus infusion proton-pump inhibitor therapy in patients with bleeding ulcers.
    Laine L; Shah A; Bemanian S
    Gastroenterology; 2008 Jun; 134(7):1836-41. PubMed ID: 18423628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors and recurrent bleeding in peptic ulcer disease.
    Tajima A; Koizumi K; Suzuki K; Higashi N; Takahashi M; Shimada T; Terano A; Hiraishi H; Kuwayama H
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S237-41. PubMed ID: 19120905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute gastroduodenal ulcers and erosion complicated by hemorrhage].
    Pinskiĭ SB; Ageenko VA; Bregel' AI
    Khirurgiia (Mosk); 1985 Oct; (10):13-7. PubMed ID: 3906239
    [No Abstract]   [Full Text] [Related]  

  • 9. [Adjuvant treatment of peptic ulcer bleeding].
    Schilling D; Hartmann D; Eickhoff A; Jakobs R; Riemann JF
    Dtsch Med Wochenschr; 2005 Feb; 130(7):344-8. PubMed ID: 15712023
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombocytopenia as a side effect of pantoprazole.
    Taş A
    Turk J Gastroenterol; 2013; 24(3):295-6. PubMed ID: 24226727
    [No Abstract]   [Full Text] [Related]  

  • 11. Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan?
    Chan FK
    J Gastroenterol Hepatol; 2010 Jan; 25(1):6-7. PubMed ID: 20136970
    [No Abstract]   [Full Text] [Related]  

  • 12. Peptic ulcer bleeding: comparison of two hemostatic procedures.
    Buffoli F; Graffeo M; Nicosia F; Gentile C; Cesari P; Rolfi F; Paterlini A
    Am J Gastroenterol; 2001 Jan; 96(1):89-94. PubMed ID: 11197294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of bleeding gastroduodenal ulcer].
    Adamsen S; de Muckadell OB
    Ugeskr Laeger; 2007 Apr; 169(17):1551-5. PubMed ID: 17484823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. It is premature to recommend low-dose intravenous proton pump inhibition after endoscopic hemostasis in patients with bleeding ulcers.
    Barkun AN; Kuipers EJ; Sung JJ
    Am J Gastroenterol; 2009 Aug; 104(8):2120-1. PubMed ID: 19661947
    [No Abstract]   [Full Text] [Related]  

  • 15. The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review.
    Bustamante M; Stollman N
    J Clin Gastroenterol; 2000 Jan; 30(1):7-13. PubMed ID: 10636205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is gastric and duodenal ulcer drug-treatable or surgical disease?].
    Fedele E
    Chir Ital; 1997; 49(1-2):5-8. PubMed ID: 12743869
    [No Abstract]   [Full Text] [Related]  

  • 17. Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.
    Lin HJ; Hsu YC
    Ann Intern Med; 2009 Oct; 151(8):589; author reply 590. PubMed ID: 19841465
    [No Abstract]   [Full Text] [Related]  

  • 18. Missed opportunities in the trial on proton-pump inhibitor therapy in bleeding peptic ulcers.
    Yih V; Tejani A
    Ann Intern Med; 2009 Oct; 151(8):588-9; author reply 590. PubMed ID: 19841463
    [No Abstract]   [Full Text] [Related]  

  • 19. [Upper gastrointestinal bleeding due to peptic ulcer].
    Ramírez FC
    Rev Gastroenterol Peru; 1996; 16(3):185-6. PubMed ID: 12165781
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of treatment of duodenal and gastric ulcers--pantoprazole vs. omeprazole.
    Schepp W; Rehner M; Witzel L
    Aliment Pharmacol Ther; 1994; 8 Suppl 1():53-7. PubMed ID: 8180295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.